Form 6-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 6-K

 

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of April 2019

Commission File Number: 001-36515

 

 

Materialise NV

 

 

Technologielaan 15

3001 Leuven

Belgium

(Address of principal executive office)

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F   ☒            Form 40-F   ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐

 

 

 


EXHIBIT INDEX

 

Exhibit

  

Description

99.1    Press Release dated April 30, 2019


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

MATERIALISE NV
By:   /s/ Wilfried Vancraen
Name:   Wilfried Vancraen
Title:   Chief Executive Officer

Date: April 30, 2019

Exhibit 99.1

Exhibit 99.1

Materialise Reports First Quarter 2019 Results

LEUVEN, Belgium—(BUSINESS WIRE)—April 30, 2019 — Materialise NV (NASDAQ:MTLS), a leading provider of additive manufacturing and medical software and of sophisticated 3D printing services, today announced its financial results for the first quarter ended March 31, 2019.

Highlights – First Quarter 2019

 

   

Total revenue increased 7.3% to 47,115 kEUR for the first quarter of 2019 from 43,899 kEUR for the first quarter of 2018.

 

   

Total deferred revenue from annual software sales and maintenance contracts increased by 2,305 kEUR to 24,911 kEUR from 22,606 kEUR at the end of 2018.

 

   

Adjusted EBITDA increased 12% from the first quarter of 2018 to 5,829 kEUR for the first quarter of 2019.

 

   

Net loss for the first quarter of 2019 was (304) kEUR, or (0.01) EUR per diluted share, compared to (183) kEUR, or 0.00 EUR per diluted share, over the same period last year.

Executive Chairman Peter Leys commented, “In the year’s opening quarter, all three of our segments performed well. Materialise Software and Materialise Medical, which continue to invest in both sales and marketing and research and development, combined healthy double-digit revenue growth rates with solid double-digit EBITDA margins. In spite of the continuing macro-economic uncertainties, in particular in the automotive sector, Materialise Manufacturing also realized growth, both in terms of revenue and, more significantly, in terms of EBITDA. We believe we are on track to meet our financial guidance for 2019.”

First Quarter 2019 Results

Total revenue for the first quarter of 2019 increased 7.3% to 47,115 kEUR compared to 43,899 kEUR for the first quarter of 2018. Adjusted EBITDA increased to 5,829 kEUR from 5,224 kEUR. The Adjusted EBITDA margin (Adjusted EBITDA divided by total revenue) in the first quarter of 2019 was 12.4% compared to 11.9% in the first quarter of 2018.

Revenue from our Materialise Software segment increased 12.3% to 9,350 kEUR for the first quarter of 2019 from 8,326 kEUR for the same quarter last year. Segment EBITDA increased to 2,961 kEUR from 2,324 kEUR while the segment EBITDA margin (the segment’s EBITDA divided by the segment’s revenue) was 31.7% compared to 27.9% in the prior-year period.

Revenue from our Materialise Medical segment increased 13.6% to 13,566 kEUR for the first quarter of 2019 compared to 11,946 kEUR for the same period in 2018. Compared to the same quarter in 2018, revenues from medical devices and services grew 15.8%, and revenues from our medical software grew 9.4%. Segment EBITDA was 1,773 kEUR compared to 2,060 kEUR while the segment EBITDA margin decreased to 13.1% from 17.2% in the first quarter of 2018.

Revenue from our Materialise Manufacturing segment increased 2.3% to 24,184 kEUR for the first quarter of 2019 from 23,632 kEUR for the first quarter of 2018. Segment EBITDA increased to 3,695 kEUR from 3,133 kEUR while the segment EBITDA margin increased to 15.3% from 13.3% for the same quarter in 2018.

Gross profit was 25,579 kEUR, or 54.3% of total revenue, for the first quarter of 2019 compared to 23,955 kEUR, or 54.6% of total revenue, for the first quarter of 2018.

Research and development (“R&D”), sales and marketing (“S&M”) and general and administrative (“G&A”) expenses increased, in the aggregate, 8.5% to 25,361 kEUR for the first quarter of 2019 from 23,374 kEUR for the first quarter of 2018.

Net other operating income increased by 709 kEUR to 1,258 kEUR compared to 549 kEUR for the first quarter of 2018.

Operating result increased 30.6% to 1,476 kEUR from 1,130 kEUR for the same period in the prior year.

Net financial result was (592) kEUR compared to (710) kEUR for the prior-year period. The share in loss of joint venture amounted to (123) kEUR from (103) kEUR for the same period last year.

The first quarter of 2019 contained income tax expenses of (1,065) kEUR, compared to (500) kEUR in the first quarter of 2018. The decrease of 565 kEUR primarily reflects the change in deferred taxes from an income of 320 kEUR as at March 31, 2018 to an expense of 290 kEUR as at March 31, 2019.


As a result of the above, net loss for the first quarter of 2019 was (304) kEUR, compared to (183) kEUR for the same period in 2018. Total comprehensive income for the first quarter of 2019, which includes exchange differences on translation of foreign operations, was 284 kEUR compared to a loss of (278) kEUR for the same period in 2018.

At March 31, 2019, we had cash and equivalents of 111,052 kEUR compared to 115,506 kEUR at December 31, 2018. Cash flow from operating activities for the first quarter of 2019 was 4,081 kEUR compared to 6,200 kEUR in 2018. As a result of the implementation of the new accounting standard IFRS 16, we have recognized additional lease assets and liabilities for an amount of 4,998 kEUR at January 1, 2019. Our Adjusted EBITDA for the first quarter of 2019 was affected positively by this new standard from the rental payments decrease of 596 kEUR, but our operating profit was not impacted as the depreciation expenses increased by the same amount.

Net shareholders’ equity at March 31, 2019 was 136,377 kEUR compared to 135,989 kEUR at December 31, 2018.

2019 Guidance

As detailed in the company’s year-end fiscal 2018 earnings announcement, in fiscal 2019, management expects to report consolidated revenue between 196,000—204,000 kEUR and Adjusted EBITDA between 29,000 – 33,000 kEUR. Management also expects the amount of deferred revenue the company generates from annual licenses and maintenance in 2019 to increase by an amount between 2,000—4,000 kEUR as compared to 2018. Reflecting the usual seasonality of the company’s business, Materialise expects its financial performance to be weighted towards the second half of 2019.

Non-IFRS Measures

Materialise uses EBITDA and Adjusted EBITDA as supplemental financial measures of its financial performance. EBITDA is calculated as net profit plus income taxes, financial expenses (less financial income), shares of loss in a joint venture and depreciation and amortization. Adjusted EBITDA is determined by adding non-cash stock-based compensation expenses and acquisition-related expenses of business combinations to EBITDA. Management believes these non-IFRS measures to be important measures as they exclude the effects of items which primarily reflect the impact of long-term investment and financing decisions, rather than the performance of the company’s day-to-day operations. As compared to net profit, these measures are limited in that they do not reflect the periodic costs of certain capitalized tangible and intangible assets used in generating revenues in the company’s business, or the charges associated with impairments. Management evaluates such items through other financial measures such as capital expenditures and cash flow provided by operating activities. The company believes that these measurements are useful to measure a company’s ability to grow or as a valuation measurement. The company’s calculation of EBITDA and Adjusted EBITDA may not be comparable to similarly titled measures reported by other companies. EBITDA and Adjusted EBITDA should not be considered as alternatives to net profit or any other performance measure derived in accordance with IFRS. The company’s presentation of EBITDA and Adjusted EBITDA should not be construed to imply that its future results will be unaffected by unusual or non-recurring items.

Exchange Rate

This document contains translations of certain euro amounts into U.S. dollars at specified rates solely for the convenience of readers. Unless otherwise noted, all translations from euros to U.S. dollars in this document were made at a rate of EUR 1.00 to USD 1.1235, the reference rate of the European Central Bank on March 29, 2019.

Conference Call and Webcast

Materialise will hold a conference call and simultaneous webcast to discuss its financial results for the first quarter of 2019 on Tuesday, April 30, 2019, at 8:30 a.m. ET/2:30 p.m. CET. Company participants on the call will include Wilfried Vancraen, Founder and Chief Executive Officer; Peter Leys, Executive Chairman; and Johan Albrecht, Chief Financial Officer. A question-and-answer session will follow management’s remarks.

To access the conference call, please dial 844-469-2530 (U.S.) or 765-507-2679 (international), passcode #4573367. The conference call will also be broadcast live over the Internet with an accompanying slide presentation, which can be accessed on the company’s website at http://investors.materialise.com.

A webcast of the conference call will be archived on the company’s website for one year.

About Materialise

Materialise incorporates more than 25 years of 3D printing experience into a range of software solutions and 3D printing services, which form the backbone of the 3D printing industry. Materialise’s open and flexible solutions enable players in a wide variety of industries, including healthcare, automotive, aerospace, art and design, and consumer goods, to build innovative 3D printing applications that aim to make the world a better and healthier place. Headquartered in Belgium, with branches worldwide, Materialise combines one of the largest groups of software developers in the industry with one of the largest 3D printing facilities in the world. For additional information, please visit: www.materialise.com.


Cautionary Statement on Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, regarding, among other things, our intentions, beliefs, assumptions, projections, outlook, analyses or current expectations, plans, objectives, strategies and prospects, both financial and business, including statements concerning, among other things, current estimates of fiscal 2019 revenues, deferred revenue from annual licenses and maintenance and Adjusted EBITDA, results of operations, cash needs, capital expenditures, expenses, financial condition, liquidity, prospects, growth and strategies (including our strategic priorities for 2019), and the trends and competition that may affect the markets, industry or us. Such statements are subject to known and unknown uncertainties and risks. When used in this press release, the words “estimate,” “expect,” “anticipate,” “project,” “plan,” “intend,” “believe,” “forecast,” “will,” “may,” “could,” “might,” “aim,” “should,” and variations of such words or similar expressions are intended to identify forward-looking statements. These forward-looking statements are based upon the expectations of management under current assumptions at the time of this press release. These expectations, beliefs and projections are expressed in good faith and the company believes there is a reasonable basis for them. However, the company cannot offer any assurance that our expectations, beliefs and projections will actually be achieved. By their nature, forward-looking statements involve risks and uncertainties because they relate to events, competitive dynamics and industry change, and depend on economic circumstances that may or may not occur in the future or may occur on longer or shorter timelines than anticipated. We caution you that forward-looking statements are not guarantees of future performance and involve known and unknown risks, uncertainties and other factors that are in some cases beyond our control. All of the forward-looking statements are subject to risks and uncertainties that may cause the company’s actual results to differ materially from our expectations, including risk factors described in the company’s annual report on Form 20-F filed with the U.S. Securities and Exchange Commission. There are a number of risks and uncertainties that could cause the company’s actual results to differ materially from the forward-looking statements contained in this press release.

The company is providing this information as of the date of this press release and does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise, unless it has obligations under the federal securities laws to update and disclose material developments related to previously disclosed information.


 

Consolidated income statements (Unaudited)

 

     For the three months ended
March 31,
    For the three months ended
March 31,
 
In 000    2019     2019     2018     2019     2018  
     U.S.$                  

Revenue

     52,934       47,115       43,899       47,115       43,899  

Cost of sales

     (24,195     (21,536     (19,944     (21,536     (19,944

Gross profit

     28,739       25,579       23,955       25,579       23,955  

Gross profit as % of revenue

     54,3     54,3     54.6     54,3     54.6

Research and development expenses

     (6,388     (5,686     (5,615     (5,686     (5,615

Sales and marketing expenses

     (13,571     (12,079     (10,599     (12,079     (10,599

General and administrative expenses

     (8,534     (7,596     (7,160     (7,596     (7,160

Net other operating income (expenses)

     1,412       1,258       549       1,258       549  

Operating (loss) profit

     1,658       1,476       1,130       1,476       1,130  

Financial expenses

     (1,344     (1,196     (1,550     (1,196     (1,550

Financial income

     679       604       840       604       840  

Share in loss of joint venture

     (139     (123     (103     (123     (103

(Loss) profit before taxes

     854       761       317       761       317  

Income taxes

     (1,196     (1,065     (500     (1,065     (500

Net (loss) profit for the period

     (342     (304     (183     (304     (183

Net (loss) profit attributable to:

          

The owners of the parent

     (342     (304     (183     (304     (183

Non-controlling interest

     —         —         —         —         —    

Earnings per share attributable to owners of the parent

 

       

Basic

     (0.01     (0.01     0.00       (0.01     0.00  

Diluted

     (0.01     (0.01     0.00       (0.01     0.00  

Weighted average basic shares outstanding

     52,891       52,891       47,428       52,891       47,428  

Weighted average diluted shares outstanding

     52,891       52,891       47,428       52,891       47,428  


 

Consolidated statements of comprehensive income (Unaudited)

 

     For the three months ended
March 31,
    For the three months ended
March 31,
 
In 000    2019     2019     2018     2019     2018  
     U.S.$                  

Net profit (loss) for the period

     (342     (304     (183     (304     (183

Other comprehensive income

          

Exchange difference on translation of foreign operations

     661       588       (95     588       (95

Other comprehensive income (loss), net of taxes

     661       588       (95     588       (95

Total comprehensive income (loss) for the year, net of taxes

     319       284       (278     284       (278

Total comprehensive income (loss) attributable to:

          

The owners of the parent

     319       284       (278     284       (278

Non-controlling interest

     —         —         —         —         —    


 

Consolidated statement of financial position (Unaudited)

 

     As of March 31,      As of
December 31,
 
In 000    2019      2018  
           

Assets

     

Non-current assets

     

Goodwill

     17,680        17,491  

Intangible assets

     26,189        26,326  

Property, plant & equipment

     97,120        92,537  

Investments in joint ventures

     

Deferred tax assets

     257        315  

Other non-current assets

     9,388        7,237  

Total non-current assets

     150,634        143,906  

Current assets

     

Inventories

     11,203        9,986  

Trade receivables

     39,397        36,891  

Other current assets

     7,172        6,936  

Cash and cash equivalents

     111,052        115,506  

Total current assets

     168,824        169,319  

Total assets

     319,458        313,225  


 

 

     As of March 31,     As of
December 31,
 
In 000    2019     2018  
          

Equity and liabilities

    

Equity

    

Share capital

     3,050       3,050  

Share premium

     136,741       136,637  

Consolidated reserves

     (2,152     (1,848

Other comprehensive income

     (1,262     (1,850

Equity attributable to the owners of the parent

     136,377       135,989  

Non-controlling interest

     —         —    

Total equity

     136,377       135,989  

Non-current liabilities

    

Loans & borrowings

     93,638       92,440  

Deferred tax liabilities

     6,484       6,226  

Deferred income

     4,813       4,587  

Other non-current liabilities

     585       868  

Total non-current liabilities

     105,520       104,121  

Current liabilities

    

Loans & borrowings

     15,517       13,598  

Trade payables

     17,128       18,667  

Tax payables

     2,730       2,313  

Deferred income

     26,476       23,195  

Other current liabilities

     15,710       15,342  

Total current liabilities

     77,561       73,115  

Total equity and liabilities

     319,458       313,225  


 

Consolidated statement of cash flows (Unaudited)

 

     For the three months ended March 31,  
in 000    2019     2018  
          

Operating activities

    

Net (loss) profit for the period

     (304     (183

Non-cash and operational adjustments

    

Depreciation of property, plant & equipment

     3,429       2,700  

Amortization of intangible assets

     1,101       1,305  

Share-based payment expense

     (177     89  

Loss (gain) on disposal of property, plant & equipment

     51        

Movement in provisions

     14       (16

Movement reserve for bad debt

     (136     84  

Financial income

     (60     (667

Financial expense

     583       1,067  

Impact of foreign currencies

     83       310  

Share in loss of a joint venture (equity method)

     124       103  

(Deferred) income taxes

     1,065       501  

Other

     35       (88

Working capital adjustment & income tax paid

    

Increase in trade receivables and other receivables

     (2,393     (4,372

Decrease (increase) in inventories

     (1,200     1,147  

Increase in trade payables and other payables

     2,251       5,027  

Income tax paid

     (385     (807

Net cash flow from operating activities

     4,081       6,200  


 

 

     For the three months ended March 31,  
in 000    2019     2018  
          

Investing activities

    

Purchase of property, plant & equipment

     (2,657     (4,275

Purchase of intangible assets

     (575     (324

Proceeds from the sale of property, plant & equipment & intangible assets (net)

     —         20  

Convertible loan to third party

     (2,500     —    

Investments in joint-ventures

     —         —    

Interest received

     53       14  

Net cash flow used in investing activities

     (5,679     (4,565

Financing activities

    

Proceeds from loans & borrowings

     1,500       12,413  

Repayment of loans & borrowings

     (2,543     (11,388

Repayment of finance leases

     (1,399     (760

Capital increase

     —         207  

Interest paid

     (503     (404

Other financial income (expense)

     (110     5  

Net cash flow from (used in) financing activities

     (3,055     73  

Net increase of cash & cash equivalents

     (4,653     1,708  

Cash & cash equivalents at beginning of the year

     115,506       43,175  

Exchange rate differences on cash & cash equivalents

     199       (186

Cash & cash equivalents at end of the year

     111,052       44,697  


 

Reconciliation of Net Profit (Loss) to EBITDA and Adjusted EBITDA (Unaudited)

 

     For the three months
ended March 31,
    For the three months
ended March 31,
 
In 000    2019     2018     2019     2018  
                  

Net profit (loss) for the period

     (304     (183     (304     (183

Income taxes

     1,065       500       1,065       500  

Financial expenses

     1,196       1,550       1,196       1,550  

Financial income

     (604     (840     (604     (840

Share in loss of joint venture

     123       103       123       103  

Depreciation and amortization

     4,530       4,006       4,530       4,006  

EBITDA

     6,006       5,136       6,006       5,136  

Non-cash stock-based compensation expense (1)

     (177     88       (177     88  

Acquisition-related expenses business combinations

     –         –         –         –    

ADJUSTED EBITDA

     5,829       5,224       5,829       5,224  

 

(1)

Non-cash stock-based compensation expenses represent the cost of equity-settled and cash-settled share-based payments to employees.


 

Segment P&L (Unaudited)

 

In 000    Materialise
Software
    Materialise
Medical
    Materialise
Manufact-
uring
    Total
segments
    Unallocated (1)     Consoli-
dated
 
                          

For the three months ended March 31, 2019

            

Revenues

     9,350       13,566       24,184       47,100       15       47,115  

Segment EBITDA

     2,961       1,773       3,695       8,429       (2,423     6,006  

Segment EBITDA %

     31.7     13.1     15.3     17.9       12.7

For the three months ended March 31, 2018

            

Revenues

     8,326       11,946       23,632       43,904       (5     43,899  

Segment EBITDA

     2,324       2,060       3,133       7,517       (2,381     5,136  

Segment EBITDA %

     27.9     17.2     13.3     17.1       11.7

 

(1)

Unallocated Revenues consist of occasional one-off sales by our core competencies not allocated to any of our segments. Unallocated Segment EBITDA consists of corporate research and development, corporate headquarter costs and other operating income (expense).


 

Reconciliation of Net Profit (Loss) to Segment EBITDA (Unaudited)

 

     For the three months ended
March 31,
    For the three months ended
March 31,
 
In 000    2019     2018     2019     2018  
                  

Net profit (loss) for the period

     (304     (183     (304     (183

Income taxes

     1,065       500       1,065       500  

Financial cost

     1,196       1,550       1,196       1,550  

Financial income

     (604     (840     (604     (840

Share in loss of joint venture

     123       103       123       103  

Operating profit

     1,476       1,130       1,476       1,130  

Depreciation and amortization

     4,530       4,006       4,530       4,006  

Corporate research and development

     464       490       464       490  

Corporate headquarter costs

     2,565       2,263       2,565       2,263  

Other operating income (expense)

     (606     (372     (606     (372

Segment EBITDA

     8,429       7,517       8,429       7,517